Albrioza (sodium phenylbutyrate and ursodoxicoltaurine)

pCPA File Number: 21945
Negotiation Status:
Concluded with an LOI
Indication(s):
amyotrophic lateral sclerosis (ALS)
Sponsor/Manufacturer:
Amylyx Canada
CADTH Project Number:
SR0711
pCPA Engagement Letter Issued:
Negotiation Process Concluded: